首页> 美国卫生研究院文献>International Journal of Environmental Research and Public Health >Survival Time of Visual Gains after Diabetic Vitrectomy and Its Relationship with Ischemic Heart Disease
【2h】

Survival Time of Visual Gains after Diabetic Vitrectomy and Its Relationship with Ischemic Heart Disease

机译:糖尿病玻璃体切除术后视力存活时间与缺血性心脏病的关系

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Vitrectomy surgery in proliferative diabetic retinopathy improves the vision-related quality of life. However, there is lack of data on the duration of maintenance of visual gains post vitrectomy. This study thus aimed to determine the survival time of visual gains and the prognostic factors of vision loss after vitrectomy surgery for complications of proliferative diabetic retinopathy. A retrospective cohort study was conducted in an ophthalmology clinic in Malaysia. We included 134 patients with type 2 diabetes mellitus on follow-up after vitrectomy for proliferative diabetic retinopathy. Visual acuity was measured using the log of minimum angle of resolution (LogMar). A gain of ≥0.3 LogMar sustained on two subsequent visits was considered evidence of visual improvement post vitrectomy. Subjects were considered to have vision loss when their post-operative visual acuity subsequently dropped by ≥0.3 LogMar. Kaplan–Meier analysis was used to determine the survival time of visual gains. Cox Proportional Hazard regression was used to determine the prognostic factors of vision loss. The median age of patients was 56.00 years (IQR ± 10.00). The median duration of diabetes mellitus was 14.00 years (IQR ± 10.00). Approximately 50% of patients with initial improvement post vitrectomy subsequently experienced vision loss. The survival time, i.e., the median time from surgery until the number of patients with vision loss formed half of the original cohort, was 14.63 months (95% CI: 9.95, 19.32). Ischemic heart disease was a significant prognostic factor of vision loss. Patients with underlying ischemic heart disease (adjusted HR: 1.97, 95% CI: 1.18, 3.33) had a higher risk of vision loss post vitrectomy, after adjusting for other factors. Approximately half the patients with initial visual gains post vitrectomy maintained their vision for at least one year. Ischemic heart disease was a poor prognostic factor for preservation of visual gains post vitrectomy.
机译:在增生性糖尿病视网膜病变中进行玻璃体切割手术可改善与视力相关的生活质量。但是,缺乏有关玻璃体切除术后视力维持时间的数据。因此,本研究旨在确定玻璃体切除术后增生性糖尿病性视网膜病并发症的视力获得生存时间和视力丧失的预后因素。回顾性队列研究在马来西亚的眼科诊所进行。我们纳入了134例玻璃体切除术后因增生性糖尿病视网膜病变而接受随访的2型糖尿病患者。使用最小分辨角的对数(LogMar)测量视敏度。在随后的两次就诊中持续获得的LogMar≥0.3 LogMar被认为是玻璃体切除术后视力改善的证据。当受试者的术后视力随后下降≥0.3LogMar时,被认为患有视力丧失。 Kaplan–Meier分析用于确定视觉增益的生存时间。 Cox比例风险回归用于确定视力丧失的预后因素。患者的中位年龄为56.00岁(IQR±10.00)。糖尿病的中位病程为14.00年(IQR±10.00)。玻璃体切除术后最初改善的患者中约有50%随后出现视力下降。生存时间,即从手术到出现视力丧失的患者人数占最初队列的一半的中位时间为14.63个月(95%CI:9.95,19.32)。缺血性心脏病是视力丧失的重要预后因素。潜在的缺血性心脏病(校正后的HR:1.97,95%CI:1.18,3.33)在进行其他因素校正后,玻璃体切除术后视力丧失的风险较高。玻璃体切除术后最初有视力增加的患者中,大约有一半的患者视力至少维持一年。缺血性心脏病是玻璃体切除术后不能保留视力的不良预后因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号